Blog

2023 Highlights from the Nautilus blog

Dive into some of our standout posts from 2023 to learn more about the Nautilus(TM) Proteome Analysis Platform and the Proteomics revolution.

Interview with Sonal Tonapi – Nautilus Manager, Probe Qualification

Sonal is a Manager leading the Nautilus team qualifying probes designed to give Nautilus Platform the ability to decode the proteome.

Interview with Martin Huber – VP of Biochemistry and Flow Cell Development

Martin Huber shares why he transitioned from genomics to proteomics and why he believes in Nautilus' potential.

Congratulations to Nautilus Founder and Chief Scientist, Parag Mallick, winner of the 2024 US HUPO Gilbert S. Omenn Computational Proteomics Award

Learn how Nautilus Founder and Chief Scientist, Parag Mallick, became interested in computational biology and has leveraged that interest for huge impacts in proteomics.

Applications of proteomics in cancer – Multiomic study highlights the value of the proteome for prostate cancer prognoses

Pairing proteomic analysis with epigenetic and transcriptomic data could soon yield more informative prostate cancer prognoses.

Applications of proteomics in cancer – assessing the potential of PROTACs

Learn how PROTACs enable researchers to exquisitely target cancer proteins for degradation and may make effective therapeutics.

Applications of proteomics in cancer – Proteomics reveals inner workings of head and neck squamous cell carcinoma (HNSCC)

Better characterizing subtypes of HNSCC could lead to more personalized treatments for the disease.

Applications of proteomics in neuroscience – Round up

Proteomics is uncovering new protein biomarkers, unveiling fundamental disease mechanics, and more in the world of neuroscience.

Applications of proteomics in neuroscience – Creating an atlas of protein changes during Alzheimer’s disease progression

A review of 38 proteomics studies identifies common protein changes in Alzheimer's disease development and progression.

Interview with Andreas Huhmer – Senior Director of Scientific Affairs and Alliance Management

Andreas, Nautilus Senior Director of Alliance Management, describes why he’s excited to see researchers begin to use the Nautilus Platform.

Applications of proteomics in cancer – Insights from a multiomic analysis of lung adenocarcinoma

Gillette et al. 2020 identify potentially druggable pathways, determinants of immune cell invasion, and multiomic connections in lung cancer.

Nautilus eBook – Proteomics and cancer

Learn how proteomics is advancing cancer research and may usher in the creation of new cancer diagnostics and treatments.